TD Asset Management »

Regulus Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $486k 302k 1.61

More positions owned by TD Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Canadian Pacific Kansas City (CP)
Amazon (AMZN)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Broadcom (AVGO)
Canadian Natural Resources (CNQ)
Cibc Cad (CM)
UnitedHealth (UNH)

View all positions for TD Asset Management

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics